SightfileU.S. market data from official filings

Companies › TXMD

TherapeuticsMD Inc (TXMD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000025743 · EDGAR filings · Updated 2026-05-12

TherapeuticsMD Inc (TXMD) has reported institutional ownership of 34.0%, with 49 institutional managers holding positions valued at $7.94M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings, triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Institutional ownership
34.0%
Institutional managers
49
Reported 13F value
$7.94M
Insider activity
5 trans.
$16.8K net buying
Data flags
3 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, TherapeuticsMD Inc has 49 institutional holders and institutional ownership of 34.0%.

Insider activity

Insiders reported 5 transactions (5 buys, 0 sells) across 2 reporting insiders, with a net reported value of $16.8K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-12 (recurring since 2020-11-09) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2023-01-12 (recurring since 2021-09-17) — source filing. The authoritative details are those stated in the filing itself.
Active triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04), most recently filed 2022-04-20 (recurring since 2022-04-20) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Bausch Lomb Corp (BLCO) · SS INNOVATIONS INTERNATIONAL COM NEW (SSII) · VISTAGEN THERAPEUTICS INC (VTGN) · VYNE THERAPEUTICS INC (VYNE) · QUOIN PHARMACEUTICALS LTD (QNRX) · DOGWOOD THERAPEUTICS INC (DWTX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-05-12.